Elucidata's climb up a $180 billion industry

One Indian startup is on its way to gain the market of a $180 billion industry. This venture is Elucidata.

Data led drug discovery offers opportunities worth $180 billion. The only problem here is that drug programmes often don’t make it till the last approval phase. According to MIT Laboratory for Financial Engineering, only 13.8% of drug programmes reach the approval stage. This rate decreases when one adds cancer drugs. They are notorious for having the lowest success rate.

But one Indian startup is on its way to change this and gain the advantages of this sector. This venture is Elucidata. It was started in 2015 by Abhishek Jha from IIT Mumbai and Swetabh Pathak from IIT Delhi. 

Jha previously worked at Agios pharmaceuticals where he realised an important lesson. Over the years, the tools for data generation has been modernised but the technology to make sense of the vast data was under-utilised. He decided to discover something that can turn the tedious life-saving drug discovery industry more fast-paced. 

Elucidata decided to bridge this gap. In 2019, they launched Polly. Polly is an AI-driven cloud-based analysis technology that can study and analyse for the scientists 100K plus biomedical datasets. The number of datasets studied by Polly is increasing at a solid pace. With Polly, they have shattered every traditional model of drug discovery.

Till 2019, Elucidata has provided analysed data for over 50 organisations spanning from biopharma to biotechnology. Some of its clientele includes MIT, Yale, Princeton and Pfizer. Polly too has gained 30+ partners including Agios, Genentech, Alnylam Therapeutics and TRV.

The venture was bootstrapped for the initial two years. In 2017 they received seed funding from Hyperplane Venture Capital of $1.7 million. With this fund, Elucidata expanded its operations in New Delhi, Bangalore, Cambridge, San Francisco and Massachusetts.

This year in January they raised Rs 36 crores or $5 million in its pre-Series A funding with IvyCap Ventures, Hyperplane Venture Capital along with a few angel investors. 

With the fresh funding, will Elucidata be able to strengthen its position as a provider of structured biomedical data to the life science industry?

Tags : #Elucidata #AbhishekJha #SwetabhPathak #biomedicaldata #datatech #smitakumar #medicircle

About the Author

Priyal Shah

Priyal Shah is a graduate of Media from Mithibai College, Mumbai. She is a writer, researcher and avid reader.

Related Stories

Loading Please wait...

Trending Now

PM addresses the Nation today, announces free vaccinesJune 07, 2021
Why inhalers are best for treating asthma, well illustrated by Dr. Anil SingalMay 12, 2021
Dr. Rohan Palshetkar shares his invaluable insights about the Maternal Mortality Rate causes and improvements in India April 29, 2021
It is important to adopt a non-judgmental attitude towards any teenage girl seeking contraceptive advise suggests Dr. Teena Trivedi, Obstetrician and GynecologistApril 16, 2021
80% of the diseases are psychosomatic which means they have roots in the mind and this is where homeopathy steps in - It resolves physical ailments by finding the cause in the mind – Dr. Sanket Dhuri, Consultant Homeopath April 14, 2021
A futuristic Vision of a Healthcare Entrepreneur: Shyatto Raha, CEO, and Founder of MyHealthcareApril 12, 2021
Saher Mehdi, Founder and Chief Scientist at wellOwise talks about aspects making healthcare more equitable and reachableApril 10, 2021
Wide variety of therapies to address autism in children explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 09, 2021
Allopathic and Homeopathic medicines should not be taken together says Dr. Sunil Mehra, Homeopath ConsultantApril 08, 2021
The charm of homeopathic medicine is that it can be taken with conventional medicines – Dr. Shruthi Shridhar, Consulting Homeopath April 08, 2021
Dissociative Identity Disorder and associated concepts explained by Dr. Vinod Kumar, Psychiatrist and Head of Mpower - The Centre (Bangalore) April 07, 2021
Dissociative Identity Disorder explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 05, 2021
Sehat Ki Baat, Karishma Ke Saath- Episode 6 Healthy Diet For Boosting Metabolism Which Can Help Thyroid Patients April 03, 2021
Significant Pointers on Kidney Health by Dr. Santosh Waigankar, Consultant Urooncologist and Robotic Surgeon at Kokilaben Dhirubhai Ambani HospitalApril 01, 2021
Dr. Vaishal Kenia, Ophthalmologist Talks About the Different Possibilities Available for the Treatment of Glaucoma Depending Upon Their Type and SeverityMarch 30, 2021
No Definitive Role of Diet in Treatment of Lymphedema but Intake of Calories, Salt and Long Chain Fatty Acids should be controlled says Dr. Ramani CVMarch 30, 2021
Dr. Kiran Chandra Patro, Senior Nephrologist Talks About Dialysis as the Temporary Process and Not a Permanent Cure for the Patients of Renal DysfunctionMarch 30, 2021
Two out of three new chronic kidney disease patients are found to have diabetes or hypertension informs Dr. Sreeharsha HarinathaMarch 30, 2021
Glaucoma Treatment: Medications or Surgery? A valuable piece of advice from Dr. Pranay Kapdia, Chairman and Medical Director of Kapadia Eye CareMarch 25, 2021
Dr. Shraddha Satav, Consultant Ophthalmologist Recommends that Everybody After 40, Should Go for the Complete Eye Checkup at Regular IntervalMarch 25, 2021